SEC Filings

< Back

SEC Filing Details

Document Details

Form

EFFECT

Filing Date

Jul 9, 2021

Document Date

Jul 9, 2021

Form Description

EFFECT

Filing Group

Other

Company

Polypid

Issuer

PolyPid Ltd.

Filing Formats

View HTML

Download PDF

Download DOC

Download XLS

Technology

PolyPid’s PLEX targeted drug delivery platform enables localized, controlled, continuous release of medication over prolonged periods of time for better patient outcomes.

D-PLEX₁₀₀

Provides safe and effective local antibiotic protection against SSI (surgical Site Infection) at the needed tissues or organs by administration during surgical procedures.

D-PLEX₁₀₀₀

Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.